Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Earnings History
Annual and quarterly earnings data from 2024 to 2024
Loading earnings history...
DMAA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
DMAA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
Download Data
Export DMAA earnings history in CSV or JSON format
Free sign-in required to download data
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Earnings Overview
As of May 8, 2026, Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) reported trailing twelve-month net income of $6M. The company earned $0.25 per diluted share over the past four quarters.
Looking at the long-term picture, DMAA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$479 in fiscal 2024, representing a new all-time high.
Drugs Made In America Acquisition Corp. Ordinary Shares maintains positive profitability with. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including HCAI (N/A net income, 3.7% margin), BRTX (-$13M net income, -2239.2% margin), NUVB (-$146M net income, -325.3% margin), DMAA has comparable earnings metrics. Compare DMAA vs HCAI →
DMAA Earnings vs Peers
Earnings metrics vs comparable public companies
DMAA Historical Earnings Data (2024–2024)
1 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $-479 | - | $-479 | $-0.06 | - | - |
See DMAA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DMAA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DMAA vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonDMAA — Frequently Asked Questions
Quick answers to the most common questions about buying DMAA stock.
Is DMAA growing earnings?
DMAA TTM EPS: $0.25. Net income: $6M. Earnings growth: N/A.
What are DMAA's profit margins?
Drugs Made In America Acquisition Corp. Ordinary Shares net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are DMAA's earnings?
DMAA earnings data spans 2024-2024. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.